Cargando…
Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
Despite recent therapeutic advances, pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies, with remarkable resistance to treatment, poor prognosis, and poor clinical outcome. More efficient therapeutic approaches are urgently needed to improve patients’ survival. R...
Autores principales: | Sereti, Evangelia, Papapostolou, Irida, Dimas, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046065/ https://www.ncbi.nlm.nih.gov/pubmed/36979869 http://dx.doi.org/10.3390/biomedicines11030890 |
Ejemplares similares
-
Recent Advances on the Anticancer Properties of Saffron (Crocus sativus L.) and Its Major Constituents
por: Lambrianidou, Andromachi, et al.
Publicado: (2020) -
Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer
por: Cho, Young‐Won, et al.
Publicado: (2022) -
Emerging liver organoid platforms and technologies
por: Lam, Do Thuy Uyen Ha, et al.
Publicado: (2021) -
Organoid modeling for cancer precision medicine
por: Cantrell, Michael A, et al.
Publicado: (2015) -
Tumor organoids: applications in cancer modeling and potentials in precision medicine
por: Xu, Hanxiao, et al.
Publicado: (2022)